Volume 32, Issue 3 (Autumn 2025)                   J Birjand Univ Med Sci. 2025, 32(3): 180-184 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ebrahimzadeh A, Jannati nasab H. Influenza vaccination: Necessity, benefits, and clinical considerations: Editorial Article. J Birjand Univ Med Sci. 2025; 32 (3) :180-184
URL: http://journal.bums.ac.ir/article-1-3553-en.html
1- Infectious Diseases Research Center, Department of Infectious Diseases, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran , mr14436@yahoo.com
2- Vali-e-Asr Hospital, Birjand University of Medical Sciences, Birjand, Iran
Abstract:   (409 Views)
Influenza is a contagious viral respiratory disease with considerable potential for severe outcomes, causing millions of infections, thousands of hospitalizations, and significant mortality across the globe annually. Annual influenza vaccination remains the most effective and reliable method for preventing the disease and its related complications. This article, using an analytical and evidence-based approach, examines the various types of influenza vaccines, their immunogenic mechanisms, effectiveness, safety, short- and long-term benefits, and potential adverse effects. It also discusses high-risk and target populations, vaccine contraindications, and the optimal timing of administration to achieve the highest level of immunity. The ultimate goal is to enhance public and professional awareness and encourage active participation in seasonal vaccination programs to reduce the burden of disease and improve community health.
Full-Text [PDF 320 kb]   (99 Downloads)    
Type of Study: Editorial | Subject: Infectious disease
Received: 2025/09/24 | Accepted: 2025/11/3 | ePublished ahead of print: 2025/11/16 | ePublished: 2026/01/5

References
1. World Health Organization. Influenza vaccines [Internet]. Geneva: WHO; 2023 [cited 2025 Sep 6]. Available from: URL: https://www.who.int/teams/global-influenza-programme/vaccines
2. Centers for Disease Control and Prevention. Influenza (Flu) Vaccines [Internet]. Atlanta: CDC; 2023 [cited 2025 Sep 6]. Available from: URL: https://www.cdc.gov/flu
3. Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2023-24 influenza season. MMWR Recomm Rep. 2023;72(3):1-24. URL: https://pubmed.ncbi.nlm.nih.gov/39197095/ [DOI:10.15585/mmwr.rr7202a1] []
4. Grohskopf LA, Blanton LH, Ferdinands JM, Chung JR, Broder KR, Talbot HK, Morgan RL, Fry AM. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season. MMWR Recomm Rep. 2022 Aug 26;71(1):1-28. URL: https://pubmed.ncbi.nlm.nih.gov/36006864/ [DOI:10.15585/mmwr.rr7101a1] [PMID] []
5. Tanner AR, Dorey RB, Brendish NJ, Clark TW. Influenza vaccination: protecting the most vulnerable. Eur Respir Rev. 2021 Jan 13;30(159):200258 URL: https://pubmed.ncbi.nlm.nih.gov/33650528/ [DOI:10.1183/16000617.0258-2020] [PMID] []
6. Blaser MJ, Cohen JI, Holland SM, editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 10th ed. Philadelphia: Elsevier; 2025. URL: https://evolve.elsevier.com/cs/product/9780323935890?role=student

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Journal of Translational Medical Research

Designed & Developed by : Yektaweb